APO RESEARCH · REPORT
Bovine Blood Plasma Derivatives
This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Product & engineering
Understand the product.
This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Selected research
Industry Research
Bovine Blood Plasma Derivatives Industry Research Report 2026
Market perspective
This report studies the Bovine Blood Plasma Derivatives market, from angles of Company, regions, product types and end industries, to analyze the status and the future. This report covers different types of bovine blood plasma derivatives.
Global Bovine Blood Plasma Derivatives key players include Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), etc. Global top three manufacturers hold a share about 30%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia Pacific, both have a share over 45 percent.
Read the full market overview
In terms of product, FBS is the largest segment, with a share over 65%. And in terms of application, the largest application is Scientific Research, followed by Industrial Production, Feed, etc.
Report Scope
This report quantifies the global Bovine Blood Plasma Derivatives market in revenue (US$ million) and, where applicable, sales volume (K Liters), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Liters) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Bovine Blood Plasma Derivatives.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bovine Blood Plasma Derivatives Market by Company
Thermo Fisher
GE Healthcare
Merck (Sigma-Aldrich)
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
VWR
Corning
Serana
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
American Protein Company
Sonac
Bovine Blood Plasma Derivatives Segment by Type
Bovine Serum
FBS
Bovine Serum Albumin
Fibrinogen
Protein Ingredient
Other
Bovine Blood Plasma Derivatives Segment by Application
Scientific Research
Industrial Production
Feed
Others
Bovine Blood Plasma Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Plasma Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Plasma Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Plasma Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bovine Blood Plasma Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bovine Blood Plasma Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bovine Blood Plasma Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Bovine Blood Plasma Derivatives Production by Manufacturers (K Liters) & (2021-2026)
Table 6. Global Bovine Blood Plasma Derivatives Production Market Share by Manufacturers
Table 7. Global Bovine Blood Plasma Derivatives Production Value by Manufacturers (US$ Million) & (2021-2026)
Table 8. Global Bovine Blood Plasma Derivatives Production Value Market Share by Manufacturers (2021-2026)
Table 9. Global Bovine Blood Plasma Derivatives Average Price (USD/L) of Manufacturers (2021-2026)
Table 10. Global Bovine Blood Plasma Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Bovine Blood Plasma Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
Table 12. Global Bovine Blood Plasma Derivatives Manufacturers, Product Type & Application
Table 13. Global Bovine Blood Plasma Derivatives Manufacturers Established Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Bovine Blood Plasma Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Thermo Fisher Company Information
Table 18. Thermo Fisher Business Overview
Table 19. Thermo Fisher Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 20. Thermo Fisher Bovine Blood Plasma Derivatives Product Portfolio
Table 21. Thermo Fisher Recent Development
Table 22. GE Healthcare Company Information
Table 23. GE Healthcare Business Overview
Table 24. GE Healthcare Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 25. GE Healthcare Bovine Blood Plasma Derivatives Product Portfolio
Table 26. GE Healthcare Recent Development
Table 27. Merck (Sigma-Aldrich) Company Information
Table 28. Merck (Sigma-Aldrich) Business Overview
Table 29. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 30. Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Product Portfolio
Table 31. Merck (Sigma-Aldrich) Recent Development
Table 32. Moregate BioTech Company Information
Table 33. Moregate BioTech Business Overview
Table 34. Moregate BioTech Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 35. Moregate BioTech Bovine Blood Plasma Derivatives Product Portfolio
Table 36. Moregate BioTech Recent Development
Table 37. Gemini Company Information
Table 38. Gemini Business Overview
Table 39. Gemini Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 40. Gemini Bovine Blood Plasma Derivatives Product Portfolio
Table 41. Gemini Recent Development
Table 42. Atlanta Biologicals Company Information
Table 43. Atlanta Biologicals Business Overview
Table 44. Atlanta Biologicals Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 45. Atlanta Biologicals Bovine Blood Plasma Derivatives Product Portfolio
Table 46. Atlanta Biologicals Recent Development
Table 47. Tissue Culture Biologicals Company Information
Table 48. Tissue Culture Biologicals Business Overview
Table 49. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 50. Tissue Culture Biologicals Bovine Blood Plasma Derivatives Product Portfolio
Table 51. Tissue Culture Biologicals Recent Development
Table 52. Bovogen Company Information
Table 53. Bovogen Business Overview
Table 54. Bovogen Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 55. Bovogen Bovine Blood Plasma Derivatives Product Portfolio
Table 56. Bovogen Recent Development
Table 57. Biowest Company Information
Table 58. Biowest Business Overview
Table 59. Biowest Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 60. Biowest Bovine Blood Plasma Derivatives Product Portfolio
Table 61. Biowest Recent Development
Table 62. Internegocios Company Information
Table 63. Internegocios Business Overview
Table 64. Internegocios Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 65. Internegocios Bovine Blood Plasma Derivatives Product Portfolio
Table 66. Internegocios Recent Development
Table 67. RMBIO Company Information
Table 68. RMBIO Business Overview
Table 69. RMBIO Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 70. RMBIO Bovine Blood Plasma Derivatives Product Portfolio
Table 71. RMBIO Recent Development
Table 72. Biological Industries Company Information
Table 73. Biological Industries Business Overview
Table 74. Biological Industries Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 75. Biological Industries Bovine Blood Plasma Derivatives Product Portfolio
Table 76. Biological Industries Recent Development
Table 77. VWR Company Information
Table 78. VWR Business Overview
Table 79. VWR Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 80. VWR Bovine Blood Plasma Derivatives Product Portfolio
Table 81. VWR Recent Development
Table 82. Corning Company Information
Table 83. Corning Business Overview
Table 84. Corning Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 85. Corning Bovine Blood Plasma Derivatives Product Portfolio
Table 86. Corning Recent Development
Table 87. Serana Company Information
Table 88. Serana Business Overview
Table 89. Serana Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 90. Serana Bovine Blood Plasma Derivatives Product Portfolio
Table 91. Serana Recent Development
Table 92. Lanzhou Minhai Company Information
Table 93. Lanzhou Minhai Business Overview
Table 94. Lanzhou Minhai Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 95. Lanzhou Minhai Bovine Blood Plasma Derivatives Product Portfolio
Table 96. Lanzhou Minhai Recent Development
Table 97. Zhejiang Tianhang Biotechnology Company Information
Table 98. Zhejiang Tianhang Biotechnology Business Overview
Table 99. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 100. Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Product Portfolio
Table 101. Zhejiang Tianhang Biotechnology Recent Development
Table 102. ExCell Bio Company Information
Table 103. ExCell Bio Business Overview
Table 104. ExCell Bio Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 105. ExCell Bio Bovine Blood Plasma Derivatives Product Portfolio
Table 106. ExCell Bio Recent Development
Table 107. Jin Yuan Kang Company Information
Table 108. Jin Yuan Kang Business Overview
Table 109. Jin Yuan Kang Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 110. Jin Yuan Kang Bovine Blood Plasma Derivatives Product Portfolio
Table 111. Jin Yuan Kang Recent Development
Table 112. American Protein Company Company Information
Table 113. American Protein Company Business Overview
Table 114. American Protein Company Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 115. American Protein Company Bovine Blood Plasma Derivatives Product Portfolio
Table 116. American Protein Company Recent Development
Table 117. Sonac Company Information
Table 118. Sonac Business Overview
Table 119. Sonac Bovine Blood Plasma Derivatives Production (K Liters), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
Table 120. Sonac Bovine Blood Plasma Derivatives Product Portfolio
Table 121. Sonac Recent Development
Table 122. Global Bovine Blood Plasma Derivatives Production Comparison by Region: 2021 VS 2025 VS 2032 (K Liters)
Table 123. Global Bovine Blood Plasma Derivatives Production by Region (2021-2026) & (K Liters)
Table 124. Global Bovine Blood Plasma Derivatives Production Market Share by Region (2021-2026)
Table 125. Global Bovine Blood Plasma Derivatives Production Forecast by Region (2027-2032) & (K Liters)
Table 126. Global Bovine Blood Plasma Derivatives Production Market Share Forecast by Region (2027-2032)
Table 127. Global Bovine Blood Plasma Derivatives Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Global Bovine Blood Plasma Derivatives Production Value by Region (2021-2026) & (US$ Million)
Table 129. Global Bovine Blood Plasma Derivatives Production Value Market Share by Region (2021-2026)
Table 130. Global Bovine Blood Plasma Derivatives Production Value Forecast by Region (2027-2032) & (US$ Million)
Table 131. Global Bovine Blood Plasma Derivatives Market Average Price (USD/L) by Region (2021-2026)
Table 132. Global Bovine Blood Plasma Derivatives Market Average Price (USD/L) by Region (2027-2032)
Table 133. Global Bovine Blood Plasma Derivatives Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Liters)
Table 134. Global Bovine Blood Plasma Derivatives Consumption by Region (2021-2026) & (K Liters)
Table 135. Global Bovine Blood Plasma Derivatives Consumption Market Share by Region (2021-2026)
Table 136. Global Bovine Blood Plasma Derivatives Forecasted Consumption by Region (2027-2032) & (K Liters)
Table 137. Global Bovine Blood Plasma Derivatives Forecasted Consumption Market Share by Region (2027-2032)
Table 138. North America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Liters)
Table 139. North America Bovine Blood Plasma Derivatives Consumption by Country (2021-2026) & (K Liters)
Table 140. North America Bovine Blood Plasma Derivatives Consumption by Country (2027-2032) & (K Liters)
Table 141. Europe Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Liters)
Table 142. Europe Bovine Blood Plasma Derivatives Consumption by Country (2021-2026) & (K Liters)
Table 143. Europe Bovine Blood Plasma Derivatives Consumption by Country (2027-2032) & (K Liters)
Table 144. Asia Pacific Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Liters)
Table 145. Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2021-2026) & (K Liters)
Table 146. Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2027-2032) & (K Liters)
Table 147. South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Liters)
Table 148. South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2021-2026) & (K Liters)
Table 149. South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2027-2032) & (K Liters)
Table 150. Global Bovine Blood Plasma Derivatives Production by Type (2021-2026) & (K Liters)
Table 151. Global Bovine Blood Plasma Derivatives Production by Type (2027-2032) & (K Liters)
Table 152. Global Bovine Blood Plasma Derivatives Production Market Share by Type (2021-2026)
Table 153. Global Bovine Blood Plasma Derivatives Production Market Share by Type (2027-2032)
Table 154. Global Bovine Blood Plasma Derivatives Production Value by Type (2021-2026) & (US$ Million)
Table 155. Global Bovine Blood Plasma Derivatives Production Value by Type (2027-2032) & (US$ Million)
Table 156. Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2021-2026)
Table 157. Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2027-2032)
Table 158. Global Bovine Blood Plasma Derivatives Price by Type (2021-2026) & (USD/L)
Table 159. Global Bovine Blood Plasma Derivatives Price by Type (2027-2032) & (USD/L)
Table 160. Global Bovine Blood Plasma Derivatives Production by Application (2021-2026) & (K Liters)
Table 161. Global Bovine Blood Plasma Derivatives Production by Application (2027-2032) & (K Liters)
Table 162. Global Bovine Blood Plasma Derivatives Production Market Share by Application (2021-2026)
Table 163. Global Bovine Blood Plasma Derivatives Production Market Share by Application (2027-2032)
Table 164. Global Bovine Blood Plasma Derivatives Production Value by Application (2021-2026) & (US$ Million)
Table 165. Global Bovine Blood Plasma Derivatives Production Value by Application (2027-2032) & (US$ Million)
Table 166. Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2021-2026)
Table 167. Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2027-2032)
Table 168. Global Bovine Blood Plasma Derivatives Price by Application (2021-2026) & (USD/L)
Table 169. Global Bovine Blood Plasma Derivatives Price by Application (2027-2032) & (USD/L)
Table 170. Key Raw Materials
Table 171. Raw Materials Key Suppliers
Table 172. Bovine Blood Plasma Derivatives Distributors List
Table 173. Bovine Blood Plasma Derivatives Customers List
Table 174. Bovine Blood Plasma Derivatives Industry Trends
Table 175. Bovine Blood Plasma Derivatives Industry Drivers
Table 176. Bovine Blood Plasma Derivatives Industry Restraints
Table 177. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Bovine Blood Plasma Derivatives Product Image
Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Bovine Serum Product Image
Figure 7. FBS Product Image
Figure 8. Bovine Serum Albumin Product Image
Figure 9. Fibrinogen Product Image
Figure 10. Protein Ingredient Product Image
Figure 11. Other Product Image
Figure 12. Scientific Research Product Image
Figure 13. Industrial Production Product Image
Figure 14. Feed Product Image
Figure 15. Others Product Image
Figure 16. Global Bovine Blood Plasma Derivatives Production Value (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Bovine Blood Plasma Derivatives Production Value (2021-2032) & (US$ Million)
Figure 18. Global Bovine Blood Plasma Derivatives Production Capacity (2021-2032) & (K Liters)
Figure 19. Global Bovine Blood Plasma Derivatives Production (2021-2032) & (K Liters)
Figure 20. Global Bovine Blood Plasma Derivatives Average Price (USD/L) & (2021-2032)
Figure 21. Global Bovine Blood Plasma Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
Figure 22. Global Top 5 and 10 Bovine Blood Plasma Derivatives Players Market Share by Production Value in 2025
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. Global Bovine Blood Plasma Derivatives Production Comparison by Region: 2021 VS 2025 VS 2032 (K Liters)
Figure 25. Global Bovine Blood Plasma Derivatives Production Market Share by Region: 2021 VS 2025 VS 2032
Figure 26. Global Bovine Blood Plasma Derivatives Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 27. Global Bovine Blood Plasma Derivatives Production Value Market Share by Region: 2021 VS 2025 VS 2032
Figure 28. North America Bovine Blood Plasma Derivatives Production Value (US$ Million) Growth Rate (2021-2032)
Figure 29. Europe Bovine Blood Plasma Derivatives Production Value (US$ Million) Growth Rate (2021-2032)
Figure 30. China Bovine Blood Plasma Derivatives Production Value (US$ Million) Growth Rate (2021-2032)
Figure 31. Japan Bovine Blood Plasma Derivatives Production Value (US$ Million) Growth Rate (2021-2032)
Figure 32. Global Bovine Blood Plasma Derivatives Consumption Comparison by Region: 2021 VS 2025 VS 2032 (K Liters)
Figure 33. Global Bovine Blood Plasma Derivatives Consumption Market Share by Region: 2021 VS 2025 VS 2032
Figure 34. North America Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 35. North America Bovine Blood Plasma Derivatives Consumption Market Share by Country (2021-2032)
Figure 36. United States Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 37. United States Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 38. Canada Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 39. Mexico Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 40. Europe Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 41. Europe Bovine Blood Plasma Derivatives Consumption Market Share by Country (2021-2032)
Figure 42. Germany Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 43. France Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 44. U.K. Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 45. Italy Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 46. Russia Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 47. Spain Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 48. Netherlands Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 49. Switzerland Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 50. Sweden Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 51. Poland Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 52. Asia Pacific Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 53. Asia Pacific Bovine Blood Plasma Derivatives Consumption Market Share by Country (2021-2032)
Figure 54. China Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 55. Japan Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 56. South Korea Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 57. India Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 58. Australia Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 59. Taiwan Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 60. Southeast Asia Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 61. South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 62. South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption Market Share by Country (2021-2032)
Figure 63. Brazil Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 64. Argentina Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 65. Chile Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 66. Turkey Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 67. GCC Countries Bovine Blood Plasma Derivatives Consumption and Growth Rate (2021-2032) & (K Liters)
Figure 68. Global Bovine Blood Plasma Derivatives Production Market Share by Type (2021-2032)
Figure 69. Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2021-2032)
Figure 70. Global Bovine Blood Plasma Derivatives Price (USD/L) by Type (2021-2032)
Figure 71. Global Bovine Blood Plasma Derivatives Production Market Share by Application (2021-2032)
Figure 72. Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2021-2032)
Figure 73. Global Bovine Blood Plasma Derivatives Price (USD/L) by Application (2021-2032)
Figure 74. Bovine Blood Plasma Derivatives Value Chain
Figure 75. Bovine Blood Plasma Derivatives Production Mode & Process
Figure 76. Direct Comparison with Distribution Share
Figure 77. Distributors Profiles
Figure 78. Bovine Blood Plasma Derivatives Industry Opportunities and Challenges
Scope & coverage.
Types
- Bovine Serum
- FBS
- Bovine Serum Albumin
- Fibrinogen
- Protein Ingredient
- Other
Applications
- Scientific Research
- Industrial Production
- Feed
- Others
Companies covered
- Thermo Fisher
- GE Healthcare
- Merck (Sigma-Aldrich)
- Moregate BioTech
- Gemini
- Atlanta Biologicals
- Tissue Culture Biologicals
- Bovogen
- Biowest
- Internegocios
- RMBIO
- Biological Industries
- VWR
- Corning
- Serana
- Lanzhou Minhai
- Zhejiang Tianhang Biotechnology
- ExCell Bio
- Jin Yuan Kang
- American Protein Company
- Sonac
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bovine Blood Plasma Derivatives by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Bovine Serum
- 2.2.3 FBS
- 2.2.4 Bovine Serum Albumin
- 2.2.5 Fibrinogen
- 2.2.6 Protein Ingredient
- 2.2.7 Other
- 2.3 Bovine Blood Plasma Derivatives by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Scientific Research
- 2.3.3 Industrial Production
- 2.3.4 Feed
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Bovine Blood Plasma Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Bovine Blood Plasma Derivatives Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Bovine Blood Plasma Derivatives Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bovine Blood Plasma Derivatives Production by Manufacturers (2021-2026)
- 3.2 Global Bovine Blood Plasma Derivatives Production Value by Manufacturers (2021-2026)
- 3.3 Global Bovine Blood Plasma Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Bovine Blood Plasma Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bovine Blood Plasma Derivatives Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Bovine Blood Plasma Derivatives Manufacturers, Product Type & Application
- 3.7 Global Bovine Blood Plasma Derivatives Manufacturers Established Date
- 3.8 Global Bovine Blood Plasma Derivatives Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher
- 4.1.1 Thermo Fisher Bovine Blood Plasma Derivatives Company Information
- 4.1.2 Thermo Fisher Bovine Blood Plasma Derivatives Business Overview
- 4.1.3 Thermo Fisher Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Product Portfolio
- 4.1.5 Thermo Fisher Recent Developments
- 4.2 GE Healthcare
- 4.2.1 GE Healthcare Bovine Blood Plasma Derivatives Company Information
- 4.2.2 GE Healthcare Bovine Blood Plasma Derivatives Business Overview
- 4.2.3 GE Healthcare Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 GE Healthcare Product Portfolio
- 4.2.5 GE Healthcare Recent Developments
- 4.3 Merck (Sigma-Aldrich)
- 4.3.1 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Company Information
- 4.3.2 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Business Overview
- 4.3.3 Merck (Sigma-Aldrich) Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Merck (Sigma-Aldrich) Product Portfolio
- 4.3.5 Merck (Sigma-Aldrich) Recent Developments
- 4.4 Moregate BioTech
- 4.4.1 Moregate BioTech Bovine Blood Plasma Derivatives Company Information
- 4.4.2 Moregate BioTech Bovine Blood Plasma Derivatives Business Overview
- 4.4.3 Moregate BioTech Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Moregate BioTech Product Portfolio
- 4.4.5 Moregate BioTech Recent Developments
- 4.5 Gemini
- 4.5.1 Gemini Bovine Blood Plasma Derivatives Company Information
- 4.5.2 Gemini Bovine Blood Plasma Derivatives Business Overview
- 4.5.3 Gemini Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Gemini Product Portfolio
- 4.5.5 Gemini Recent Developments
- 4.6 Atlanta Biologicals
- 4.6.1 Atlanta Biologicals Bovine Blood Plasma Derivatives Company Information
- 4.6.2 Atlanta Biologicals Bovine Blood Plasma Derivatives Business Overview
- 4.6.3 Atlanta Biologicals Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Atlanta Biologicals Product Portfolio
- 4.6.5 Atlanta Biologicals Recent Developments
- 4.7 Tissue Culture Biologicals
- 4.7.1 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Company Information
- 4.7.2 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Business Overview
- 4.7.3 Tissue Culture Biologicals Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Tissue Culture Biologicals Product Portfolio
- 4.7.5 Tissue Culture Biologicals Recent Developments
- 4.8 Bovogen
- 4.8.1 Bovogen Bovine Blood Plasma Derivatives Company Information
- 4.8.2 Bovogen Bovine Blood Plasma Derivatives Business Overview
- 4.8.3 Bovogen Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Bovogen Product Portfolio
- 4.8.5 Bovogen Recent Developments
- 4.9 Biowest
- 4.9.1 Biowest Bovine Blood Plasma Derivatives Company Information
- 4.9.2 Biowest Bovine Blood Plasma Derivatives Business Overview
- 4.9.3 Biowest Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Biowest Product Portfolio
- 4.9.5 Biowest Recent Developments
- 4.10 Internegocios
- 4.10.1 Internegocios Bovine Blood Plasma Derivatives Company Information
- 4.10.2 Internegocios Bovine Blood Plasma Derivatives Business Overview
- 4.10.3 Internegocios Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Internegocios Product Portfolio
- 4.10.5 Internegocios Recent Developments
- 4.11 RMBIO
- 4.11.1 RMBIO Bovine Blood Plasma Derivatives Company Information
- 4.11.2 RMBIO Bovine Blood Plasma Derivatives Business Overview
- 4.11.3 RMBIO Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 RMBIO Product Portfolio
- 4.11.5 RMBIO Recent Developments
- 4.12 Biological Industries
- 4.12.1 Biological Industries Bovine Blood Plasma Derivatives Company Information
- 4.12.2 Biological Industries Bovine Blood Plasma Derivatives Business Overview
- 4.12.3 Biological Industries Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Biological Industries Product Portfolio
- 4.12.5 Biological Industries Recent Developments
- 4.13 VWR
- 4.13.1 VWR Bovine Blood Plasma Derivatives Company Information
- 4.13.2 VWR Bovine Blood Plasma Derivatives Business Overview
- 4.13.3 VWR Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 VWR Product Portfolio
- 4.13.5 VWR Recent Developments
- 4.14 Corning
- 4.14.1 Corning Bovine Blood Plasma Derivatives Company Information
- 4.14.2 Corning Bovine Blood Plasma Derivatives Business Overview
- 4.14.3 Corning Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Corning Product Portfolio
- 4.14.5 Corning Recent Developments
- 4.15 Serana
- 4.15.1 Serana Bovine Blood Plasma Derivatives Company Information
- 4.15.2 Serana Bovine Blood Plasma Derivatives Business Overview
- 4.15.3 Serana Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Serana Product Portfolio
- 4.15.5 Serana Recent Developments
- 4.16 Lanzhou Minhai
- 4.16.1 Lanzhou Minhai Bovine Blood Plasma Derivatives Company Information
- 4.16.2 Lanzhou Minhai Bovine Blood Plasma Derivatives Business Overview
- 4.16.3 Lanzhou Minhai Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Lanzhou Minhai Product Portfolio
- 4.16.5 Lanzhou Minhai Recent Developments
- 4.17 Zhejiang Tianhang Biotechnology
- 4.17.1 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Company Information
- 4.17.2 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Business Overview
- 4.17.3 Zhejiang Tianhang Biotechnology Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Zhejiang Tianhang Biotechnology Product Portfolio
- 4.17.5 Zhejiang Tianhang Biotechnology Recent Developments
- 4.18 ExCell Bio
- 4.18.1 ExCell Bio Bovine Blood Plasma Derivatives Company Information
- 4.18.2 ExCell Bio Bovine Blood Plasma Derivatives Business Overview
- 4.18.3 ExCell Bio Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.18.4 ExCell Bio Product Portfolio
- 4.18.5 ExCell Bio Recent Developments
- 4.19 Jin Yuan Kang
- 4.19.1 Jin Yuan Kang Bovine Blood Plasma Derivatives Company Information
- 4.19.2 Jin Yuan Kang Bovine Blood Plasma Derivatives Business Overview
- 4.19.3 Jin Yuan Kang Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.19.4 Jin Yuan Kang Product Portfolio
- 4.19.5 Jin Yuan Kang Recent Developments
- 4.20 American Protein Company
- 4.20.1 American Protein Company Bovine Blood Plasma Derivatives Company Information
- 4.20.2 American Protein Company Bovine Blood Plasma Derivatives Business Overview
- 4.20.3 American Protein Company Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.20.4 American Protein Company Product Portfolio
- 4.20.5 American Protein Company Recent Developments
- 4.21 Sonac
- 4.21.1 Sonac Bovine Blood Plasma Derivatives Company Information
- 4.21.2 Sonac Bovine Blood Plasma Derivatives Business Overview
- 4.21.3 Sonac Bovine Blood Plasma Derivatives Production Capacity, Value and Gross Margin (2021-2026)
- 4.21.4 Sonac Product Portfolio
- 4.21.5 Sonac Recent Developments
5 Global Bovine Blood Plasma Derivatives Production by Region
- 5.1 Global Bovine Blood Plasma Derivatives Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bovine Blood Plasma Derivatives Production by Region: 2021-2032
- 5.2.1 Global Bovine Blood Plasma Derivatives Production by Region: 2021-2026
- 5.2.2 Global Bovine Blood Plasma Derivatives Production Forecast by Region (2027-2032)
- 5.3 Global Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Bovine Blood Plasma Derivatives Production Value by Region: 2021-2032
- 5.4.1 Global Bovine Blood Plasma Derivatives Production Value by Region: 2021-2026
- 5.4.2 Global Bovine Blood Plasma Derivatives Production Value Forecast by Region (2027-2032)
- 5.5 Global Bovine Blood Plasma Derivatives Market Price Analysis by Region (2021-2026)
- 5.6 Global Bovine Blood Plasma Derivatives Production and Value, YOY Growth
- 5.6.1 North America Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Bovine Blood Plasma Derivatives Production Value Estimates and Forecasts (2021-2032)
6 Global Bovine Blood Plasma Derivatives Consumption by Region
- 6.1 Global Bovine Blood Plasma Derivatives Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bovine Blood Plasma Derivatives Consumption by Region (2021-2032)
- 6.2.1 Global Bovine Blood Plasma Derivatives Consumption by Region: 2021-2026
- 6.2.2 Global Bovine Blood Plasma Derivatives Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bovine Blood Plasma Derivatives Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bovine Blood Plasma Derivatives Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bovine Blood Plasma Derivatives Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Bovine Blood Plasma Derivatives Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Bovine Blood Plasma Derivatives Production by Type (2021-2032)
- 7.1.1 Global Bovine Blood Plasma Derivatives Production by Type (2021-2032) & (K Liters)
- 7.1.2 Global Bovine Blood Plasma Derivatives Production Market Share by Type (2021-2032)
- 7.2 Global Bovine Blood Plasma Derivatives Production Value by Type (2021-2032)
- 7.2.1 Global Bovine Blood Plasma Derivatives Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Bovine Blood Plasma Derivatives Production Value Market Share by Type (2021-2032)
- 7.3 Global Bovine Blood Plasma Derivatives Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Bovine Blood Plasma Derivatives Production by Application (2021-2032)
- 8.1.1 Global Bovine Blood Plasma Derivatives Production by Application (2021-2032) & (K Liters)
- 8.1.2 Global Bovine Blood Plasma Derivatives Production Market Share by Application (2021-2032)
- 8.2 Global Bovine Blood Plasma Derivatives Production Value by Application (2021-2032)
- 8.2.1 Global Bovine Blood Plasma Derivatives Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Bovine Blood Plasma Derivatives Production Value Market Share by Application (2021-2032)
- 8.3 Global Bovine Blood Plasma Derivatives Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Bovine Blood Plasma Derivatives Value Chain Analysis
- 9.1.1 Bovine Blood Plasma Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Bovine Blood Plasma Derivatives Production Mode & Process
- 9.2 Bovine Blood Plasma Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bovine Blood Plasma Derivatives Distributors
- 9.2.3 Bovine Blood Plasma Derivatives Customers
10 Global Bovine Blood Plasma Derivatives Analyzing Market Dynamics
- 10.1 Bovine Blood Plasma Derivatives Industry Trends
- 10.2 Bovine Blood Plasma Derivatives Industry Drivers
- 10.3 Bovine Blood Plasma Derivatives Industry Opportunities and Challenges
- 10.4 Bovine Blood Plasma Derivatives Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst